ACOG (ACOG) Earnings Call Analysis

14/25

Growth 4 Margin 3 Expansion 3 Platform 1 Financial 3

latest quarter score

Earnings Reports

14
Alpha Cognition (ACOG) Q2 2026: Zunvale Sales Surge 71%, Commercial Momentum Builds Despite Payer Access Delays
August 17, 2026
13
Alpha Cognition (ACOG) Q1 2026: 62% Zunvel Demand Surge Signals Inflection in Long-Term Care Penetration
May 15, 2026
11
Alpha Cognition (ACOG) Q4 2025: Zunvel Prescriber Base Expands 50% as Repeat Orders Anchor Growth Trajectory
March 27, 2026
14
Alpha Cognition (ACOG) Q3 2025: Zunvale Demand Bottles Double, 70% Repeat Orders Signal Deepening LTC Penetration
November 14, 2025
13
Alpha Cognition (ACOG) Q2 2025: Zunval Drives 65% Repeat Orders, Signaling Early LTC Market Traction
August 14, 2025
13
Alpha Cognition (ACOG) Q1 2025: Zunvale Launch Drives Initial Revenue and Expands Patent Protection
May 15, 2025
9
Alpha Cognition (ACOG) Q4 2024: $52M Capital Raise Fuels Zunvel Launch in Long-Term Care
March 31, 2025

Browse all companies